These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Clinical experience with an ethinyl estradiol-desogestrel oral contraceptive.
    Author: Van Trappen Y, Duvivier P, Thiery M, Van Kets H, Defoort P, Parewijck W, Derom R, Kermans G, Schoofs P.
    Journal: Arzneimittelforschung; 1989 Jun; 39(6):717-9. PubMed ID: 2528355.
    Abstract:
    Desogestrel (150 micrograms), a potent progestogen virtually devoid of androgenic activity, was used in combination with 30 micrograms ethinyl estradiol as an oral contraceptive preparation (Marvelon). 219 women completed a total of 4074 cycles, and the use-effectiveness was 0.58 Pearl Units. Serious side effects were not observed. The drug-related discontinuation index was 12.8% in six months.
    [Abstract] [Full Text] [Related] [New Search]